Without getting into a discussion about the American healthcare system, it’s no secret that mental health treatment could stand to see some improvement. The National Institute of Mental Health estimates that 6.7% of Americans have suffered a major depressive episode....
In August 2016, Janssen Research & Development—a Janssen Pharmaceutical Company of Johnson & Johnson—announced that an isomer of ketamine, called esketamine, had received Breakthrough Therapy Designation by the Food & Drug Administration (FDA). Similarly...
When it comes to the relationship between chronic pain and depression, it’s very much a chicken-or-the-egg type of debate. The physical manifestations of depression—while hard to explain—can be quite painful: back pain, migraine headaches, etc. The mental...
Since the beginning of the century, statistics have favored the use of ketamine for the treatment of depression. With upwards of 70% of patients responding favorably to the depression treatment, ketamine has been hailed as the most remarkable antidepressant discovery...
It’s a frustrating situation, to have this miraculous drug – a drug that is capable of changing and saving lives – so readily available, and yet so inaccessible. Without FDA approval, the overwhelming majority of insurance companies will not cover the cost of ketamine...
